The authorities in Italy have granted commercialization approval for GW Pharmaceuticals' Sativex prescription medication. Sativex is indicated for the treatment of moderate to severe spasticity in multiple sclerosis (MS) in patients who ...
Tags: GW Pharmaceutical, Medicine